Finance

Beta
Lists
FHTX:NASDAQ
Foghorn Therapeutics Inc
$3.74
0.00%
(0.00) 1D
Jun 4, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FHTX...
Mkt. cap
219.59M
Avg. vol.
150.41K
Volume
108.00
52-wk high
$6.95
52-wk low
$3.27
EPS
-$1.17
Beta
2.89
Shares outstanding
58.71M
No. of employees
106
Mkt. cap
219.59M
Avg. vol.
150.41K
Volume
108.00
52-wk high
$6.95
52-wk low
$3.27
EPS
-$1.17
Beta
2.89
Shares outstanding
58.71M
No. of employees
106
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to FHTX in the past 3 months
Strong Buy
Buy
6
Hold
0
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for FHTX in the last 3 months.
Highest
Current $3.74
$13.00 (+247.59%)
Average
$11.60 (+210.16%)
Lowest
$10.00 (+167.38%)
News stories
From sources across the web
About Foghorn Therapeutics Inc
CEO-
Employees106
Founded2015
Headquarters-
SectorBiotechnology
Websitefoghorntx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
7.56M
8.15M
9.25M
3.27M
Cost of goods sold
21.79M
20.00M
22.05M
18.26M
Cost of revenue
21.79M
20.00M
22.05M
18.26M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.86M
6.65M
6.80M
6.58M
Operating expense
6.86M
6.65M
6.80M
6.58M
Total operating expenses
28.65M
26.65M
28.84M
24.84M
Operating income
-21.10M
-18.50M
-19.60M
-21.57M
Other non operating income
852.00K
620.00K
502.00K
-44.00K
EBT including unusual items
-17.94M
-15.85M
-21.66M
-19.88M
EBT excluding unusual items
-17.94M
-15.85M
-17.38M
-19.88M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-17.94M
-15.85M
-21.66M
-19.88M
Net profit margin
-237.34%
-194.39%
-234.28%
-608.36%
Earnings per share
-0.28
-0.25
-0.37
-0.29
Interest and investment income
2.31M
2.03M
1.71M
1.74M
Interest expense
-
-
-
-
Net interest expenses
2.31M
2.03M
1.71M
1.74M
Depreciation and amortization charges
-
-
-
-
EBITDA
-20.25M
-17.65M
-18.79M
-21.34M
Gain or loss from assets sale
-
-
31.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer